Please login to the form below

Not currently logged in
Email:
Password:

AndroGel

This page shows the latest AndroGel news and features for those working in and with pharma, biotech and healthcare.

AbbVie sales jump on strong Humira gains

AbbVie sales jump on strong Humira gains

Among other products, HIV therapy Kaletra (lopinavir/ ritonavir) rose 1.1 per cent to $278m, while revenue from testosterone replacement therapy AndroGel fell 6.5 per cent to $258m.

Latest news

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics